Autoimmune Thrombocytopenia in Chronic Myeloid Leukemia Treated with Interferon-alpha: Differential Diagnosis and Possible Pathogenesis

Interferon-α (INF-α) is an effective anti-neoplastic and anti-viral drug. Treatment with INF-α is frequently complicated by adverse effects, which may rarely be immune mediated. We report 2 patients with Ph+ chronic myeloid leukemia (CML) who developed autoimmune thrombocytopenia while receiving mon...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2003-12, Vol.44 (12), p.2103-2108
Main Authors: Herishanu, Yair, Trestman, Svetlana, Kirgner, Ilya, Rachmani, Rodica, Naparstek, Ella
Format: Article
Language:English
Subjects:
Adult
Aged
Autoimmune Diseases - diagnosis
Autoimmune Diseases - pathology
Autoimmune thrombocytopenia
Chronic myeloid leukemia
Diagnosis, Differential
Female
Humans
Interferon-alpha - adverse effects
Interferon-α
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Male
Middle Aged
Models, Biological
Thrombocytopenia - diagnosis
Thrombocytopenia - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793
cites cdi_FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793
container_end_page 2108
container_issue 12
container_start_page 2103
container_title Leukemia & lymphoma
container_volume 44
creator Herishanu, Yair
Trestman, Svetlana
Kirgner, Ilya
Rachmani, Rodica
Naparstek, Ella
description Interferon-α (INF-α) is an effective anti-neoplastic and anti-viral drug. Treatment with INF-α is frequently complicated by adverse effects, which may rarely be immune mediated. We report 2 patients with Ph+ chronic myeloid leukemia (CML) who developed autoimmune thrombocytopenia while receiving months of treatment with INF-α. This complication responded well to discontinuation of interferon and administration of steroids treatment. Here, we also summarize the literature on INF-α induced autoimmune thrombocytopenia, and discuss differential diagnosis and possible mechanisms involved in the development of thrombocytopenia during therapy with INF-α.
doi_str_mv 10.1080/1042819031000123447
format article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_miscellaneous_19851399</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19851399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793</originalsourceid><addsrcrecordid>eNqFkV1rFDEUhoNYbK3-AkFy5d1oMsl8CQpl60dhxV6s1-FM5kwnNZOsSYayv6B_u1l2QYRSL0Jycp7znuS8hLzh7D1nLfvAmSxb3jHBGWO8FFI2z8gZZ2VXlJKJ5_uzLIuMyFPyMsbbjFVdXb4gp1x2VddW1Rm5v1iSN_O8OKSbKfi593qX_BadAWocXeU7ZzT9sUPrzUDXuPzGOec2ASHhQO9MmuiVSxhGzGgBdjvBR3ppxhyjSwZsDuDG-WgiBTfQax-j6S3Sa0iTv0GHOfOKnIxgI74-7ufk19cvm9X3Yv3z29XqYl1oKXkqulKwQZdDhQisapiudTMK0Yoa-67WCKKXXAoNgwCuedtiJVouaylRcNl04py8O-hug_-zYExqNlGjteDQL1E1vMpyef0P5Hl-XHR7RXEAdcgfCziqbTAzhJ3iTO2NUo8YlaveHuWXfsbhb83RmQx8PgDGjT7McOeDHVSCnfVhDOC0iUo83eHTPwITgk2ThoDq1i_B5Sk_-cIHWVO12A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19851399</pqid></control><display><type>article</type><title>Autoimmune Thrombocytopenia in Chronic Myeloid Leukemia Treated with Interferon-alpha: Differential Diagnosis and Possible Pathogenesis</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Herishanu, Yair ; Trestman, Svetlana ; Kirgner, Ilya ; Rachmani, Rodica ; Naparstek, Ella</creator><creatorcontrib>Herishanu, Yair ; Trestman, Svetlana ; Kirgner, Ilya ; Rachmani, Rodica ; Naparstek, Ella</creatorcontrib><description>Interferon-α (INF-α) is an effective anti-neoplastic and anti-viral drug. Treatment with INF-α is frequently complicated by adverse effects, which may rarely be immune mediated. We report 2 patients with Ph+ chronic myeloid leukemia (CML) who developed autoimmune thrombocytopenia while receiving months of treatment with INF-α. This complication responded well to discontinuation of interferon and administration of steroids treatment. Here, we also summarize the literature on INF-α induced autoimmune thrombocytopenia, and discuss differential diagnosis and possible mechanisms involved in the development of thrombocytopenia during therapy with INF-α.</description><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.1080/1042819031000123447</identifier><identifier>PMID: 14959855</identifier><language>eng</language><publisher>United States: Informa UK Ltd</publisher><subject>Adult ; Aged ; Autoimmune Diseases - diagnosis ; Autoimmune Diseases - pathology ; Autoimmune thrombocytopenia ; Chronic myeloid leukemia ; Diagnosis, Differential ; Female ; Humans ; Interferon-alpha - adverse effects ; Interferon-α ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Male ; Middle Aged ; Models, Biological ; Thrombocytopenia - diagnosis ; Thrombocytopenia - pathology</subject><ispartof>Leukemia &amp; lymphoma, 2003-12, Vol.44 (12), p.2103-2108</ispartof><rights>2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793</citedby><cites>FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14959855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herishanu, Yair</creatorcontrib><creatorcontrib>Trestman, Svetlana</creatorcontrib><creatorcontrib>Kirgner, Ilya</creatorcontrib><creatorcontrib>Rachmani, Rodica</creatorcontrib><creatorcontrib>Naparstek, Ella</creatorcontrib><title>Autoimmune Thrombocytopenia in Chronic Myeloid Leukemia Treated with Interferon-alpha: Differential Diagnosis and Possible Pathogenesis</title><title>Leukemia &amp; lymphoma</title><addtitle>Leuk Lymphoma</addtitle><description>Interferon-α (INF-α) is an effective anti-neoplastic and anti-viral drug. Treatment with INF-α is frequently complicated by adverse effects, which may rarely be immune mediated. We report 2 patients with Ph+ chronic myeloid leukemia (CML) who developed autoimmune thrombocytopenia while receiving months of treatment with INF-α. This complication responded well to discontinuation of interferon and administration of steroids treatment. Here, we also summarize the literature on INF-α induced autoimmune thrombocytopenia, and discuss differential diagnosis and possible mechanisms involved in the development of thrombocytopenia during therapy with INF-α.</description><subject>Adult</subject><subject>Aged</subject><subject>Autoimmune Diseases - diagnosis</subject><subject>Autoimmune Diseases - pathology</subject><subject>Autoimmune thrombocytopenia</subject><subject>Chronic myeloid leukemia</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Humans</subject><subject>Interferon-alpha - adverse effects</subject><subject>Interferon-α</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Thrombocytopenia - diagnosis</subject><subject>Thrombocytopenia - pathology</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkV1rFDEUhoNYbK3-AkFy5d1oMsl8CQpl60dhxV6s1-FM5kwnNZOsSYayv6B_u1l2QYRSL0Jycp7znuS8hLzh7D1nLfvAmSxb3jHBGWO8FFI2z8gZZ2VXlJKJ5_uzLIuMyFPyMsbbjFVdXb4gp1x2VddW1Rm5v1iSN_O8OKSbKfi593qX_BadAWocXeU7ZzT9sUPrzUDXuPzGOec2ASHhQO9MmuiVSxhGzGgBdjvBR3ppxhyjSwZsDuDG-WgiBTfQax-j6S3Sa0iTv0GHOfOKnIxgI74-7ufk19cvm9X3Yv3z29XqYl1oKXkqulKwQZdDhQisapiudTMK0Yoa-67WCKKXXAoNgwCuedtiJVouaylRcNl04py8O-hug_-zYExqNlGjteDQL1E1vMpyef0P5Hl-XHR7RXEAdcgfCziqbTAzhJ3iTO2NUo8YlaveHuWXfsbhb83RmQx8PgDGjT7McOeDHVSCnfVhDOC0iUo83eHTPwITgk2ThoDq1i_B5Sk_-cIHWVO12A</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Herishanu, Yair</creator><creator>Trestman, Svetlana</creator><creator>Kirgner, Ilya</creator><creator>Rachmani, Rodica</creator><creator>Naparstek, Ella</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20031201</creationdate><title>Autoimmune Thrombocytopenia in Chronic Myeloid Leukemia Treated with Interferon-alpha: Differential Diagnosis and Possible Pathogenesis</title><author>Herishanu, Yair ; Trestman, Svetlana ; Kirgner, Ilya ; Rachmani, Rodica ; Naparstek, Ella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Autoimmune Diseases - diagnosis</topic><topic>Autoimmune Diseases - pathology</topic><topic>Autoimmune thrombocytopenia</topic><topic>Chronic myeloid leukemia</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Humans</topic><topic>Interferon-alpha - adverse effects</topic><topic>Interferon-α</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Thrombocytopenia - diagnosis</topic><topic>Thrombocytopenia - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herishanu, Yair</creatorcontrib><creatorcontrib>Trestman, Svetlana</creatorcontrib><creatorcontrib>Kirgner, Ilya</creatorcontrib><creatorcontrib>Rachmani, Rodica</creatorcontrib><creatorcontrib>Naparstek, Ella</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia &amp; lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herishanu, Yair</au><au>Trestman, Svetlana</au><au>Kirgner, Ilya</au><au>Rachmani, Rodica</au><au>Naparstek, Ella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autoimmune Thrombocytopenia in Chronic Myeloid Leukemia Treated with Interferon-alpha: Differential Diagnosis and Possible Pathogenesis</atitle><jtitle>Leukemia &amp; lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>44</volume><issue>12</issue><spage>2103</spage><epage>2108</epage><pages>2103-2108</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><abstract>Interferon-α (INF-α) is an effective anti-neoplastic and anti-viral drug. Treatment with INF-α is frequently complicated by adverse effects, which may rarely be immune mediated. We report 2 patients with Ph+ chronic myeloid leukemia (CML) who developed autoimmune thrombocytopenia while receiving months of treatment with INF-α. This complication responded well to discontinuation of interferon and administration of steroids treatment. Here, we also summarize the literature on INF-α induced autoimmune thrombocytopenia, and discuss differential diagnosis and possible mechanisms involved in the development of thrombocytopenia during therapy with INF-α.</abstract><cop>United States</cop><pub>Informa UK Ltd</pub><pmid>14959855</pmid><doi>10.1080/1042819031000123447</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1042-8194
ispartof Leukemia & lymphoma, 2003-12, Vol.44 (12), p.2103-2108
issn 1042-8194
1029-2403
language eng
recordid cdi_proquest_miscellaneous_19851399
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Adult
Aged
Autoimmune Diseases - diagnosis
Autoimmune Diseases - pathology
Autoimmune thrombocytopenia
Chronic myeloid leukemia
Diagnosis, Differential
Female
Humans
Interferon-alpha - adverse effects
Interferon-α
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Male
Middle Aged
Models, Biological
Thrombocytopenia - diagnosis
Thrombocytopenia - pathology
title Autoimmune Thrombocytopenia in Chronic Myeloid Leukemia Treated with Interferon-alpha: Differential Diagnosis and Possible Pathogenesis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A31%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autoimmune%20Thrombocytopenia%20in%20Chronic%20Myeloid%20Leukemia%20Treated%20with%20Interferon-alpha:%20Differential%20Diagnosis%20and%20Possible%20Pathogenesis&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Herishanu,%20Yair&rft.date=2003-12-01&rft.volume=44&rft.issue=12&rft.spage=2103&rft.epage=2108&rft.pages=2103-2108&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.1080/1042819031000123447&rft_dat=%3Cproquest_infor%3E19851399%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-9230dc2d5eea0570c6c7f33836eb96cea3b4143cad3a1c188e53814644e314793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19851399&rft_id=info:pmid/14959855&rfr_iscdi=true